Lifeboat Foundation

OpenAI today unveiled an upgraded version of its text-to-image tool, DALL-E, that uses ChatGPT — OpenAI’s viral AI chatbot — to take some of the pain out of prompting.

Most cutting-edge, AI-powered image generation tools today take prompts — descriptions of images — and turn them into artwork in an array of styles, ranging from the photorealistic to fantastical. But crafting the right prompt can be a challenge, so much so that “prompt engineering” is becoming a bona fide profession.

OpenAI’s new tool, DALL-E 3, uses ChatGPT to help fill in prompts. Via ChatGPT, subscribers to OpenAI’s premium ChatGPT plans, ChatGPT Plus and ChatGPT Enterprise, can type in a request for an image and hone it through conversations with the chatbot — receiving the results directly within the chat app.

Cisco has a reputation of building the company through acquisitions, but it has tended to stay away from the really huge ones. That changed this morning when the company announced it was acquiring Splunk for $28 billion.

With Splunk, it gets an observability platform that could fit nicely into its security business to help customers better understand security threats, while also helping parse oodles of log data to resolve other problems like helping understand system failures or troubleshoot myriad issues across a broad array of enterprise systems.

Under the terms of the deal, Cisco is paying a hefty premium of $157 per share. When you consider that the 52-week low was $65 a share and it has hovered in the high 80s and low 90s much of this year, that’s a big bump for Splunk stockholders and suggests there might have been some competition for the logging giant. The company’s most recent market cap sits at just over $20 billion.

Since its launch in 2017, Harness, the software delivery platform founded by AppDynamics founder and CEO Jyoti Bansal, expanded from being continuous code deployment to covering continuous integration, feature flags, cloud cost management, security testing orchestration, chaos engineering and more. But even though it focused heavily on GitOps, it never offered its own Git repositories. That’s changing today with the launch of the Gitness open-source Git repository and the Harness Code Repository, the hosted and managed version of Gitness.

“There hasn’t been a new Git repo launch in almost a decade,” Bansal told me. “Now you have GitHub, GitLab, Bitbucket from Atlassian, but that’s really it. […] If you look at any of the git repos, whether it’s GitLab or GitHub or Bitbucket, they don’t have the true one source ethos around them anymore. We strongly believe that Git started as open source, so let’s bring the true open-source ethos back to Git repos.”

Neuralink’s brain implants could help protect humanity from the risks of artificial intelligence, Elon Musk said on Wednesday, as the company prepares to launch its first in-human trials for the chips it hopes could restore lost functions to people with paralysis.

Neuralink will hopefully play a role in cutting the “civilizational risk” artificial intelligence poses to humanity, Musk said in a post on X.

The implantable tech will allow humans to interact with computers with their thoughts alone and should improve our abilities to communicate with AI “by several orders of magnitude,” Musk explained.

Continue reading “Elon Musk Says Neuralink Could Slash Risk From AI As Firm Prepares For First Human Trials” »

Many ophthalmologists’ offices around the country are home to a machine that enables doctors to take advantage of optical coherence tomography (OCT), a method of imaging the retina and other tissues in the eye. These OCT machines give doctors insight into the three-dimensional structures of their patients’ eyes, help them diagnose diseases and can even help save their patients’ sight.

The genesis of OCT machines began in the lab of Dr. James Fujimoto, who was inspired by advances in high-speed photography and lasers to start developing potential methods that would enable doctors to get better images of what was happening inside of people’s bodies. The goal, he told Forbes, was to develop… More.

In 1991, the trio published their first paper describing the technique they invented. “In less than a year, we were able to develop this new imaging technology, which in retrospect was pretty unusual,” Huang told Forbes.

Continue reading “Retinal Imaging And Machine Learning Honored In The 2023 Lasker Awards” »

The developer also used OpenAI’s DALL-E to create an image for the token.

ChatGPT just engineered, designed, and marketed a cryptocurrency coin called AstroPepeX. The developer, who goes by the name CroissantEth on X, used the AI chatbot to write a crypto contract to create its own token on the blockchain, gave the name ‘AstroPepeX’ to the token, and even created a ticker – $APX for it.

Continue reading “ChatGPT’s crypto token makes $12 million in trading on day 1” »

DeepMind has released a catalog of 71 million possible variants that can cause diseases.

Genetic mutations are changes to our DNA sequence. This happens when cells make copies of themselves during cell division. Mutation is the ultimate source of human genetic variation and has evolutionary and disease genetics implications. A mutation affecting our genes might give birth to a genetic disorder. But just because you have a mutation doesn’t mean it will be a genetic disorder.

That is why researchers at DeepMind, the artificial intelligence arm of Google, have announced that they have trained a machine learning model called AlphaMissense to classify which DNA variations in our genomes are likely to cause disease.

What if we told you that we can actually silence a noisy table right next to us in a café?

It is simple to prevent participants from talking over others in online meetings by pressing the mute button. What if we told you we could try to silence a noisy table right next to us in a café?

While this concept may appear like something out of science fiction movies, some innovators have made attempts to bring it to life.

Continue reading “Noise-canceling robots to ‘mute’ loud conversations in cafe” »

Past tests have been conducted on pigs.

On Tuesday, Elon Musk’s Neuralink announced it was ready to start its first human trials. “We are happy to announce that we’ve received approval from the reviewing independent institutional review board and our first hospital site to begin recruitment for our first-in-human clinical trial,” noted a blog on the company’s website.

The PRIME Study (short for Precise Robotically Implanted Brain-Computer Interface) – a groundbreaking investigational medical device trial for our fully-implantable, wireless brain-computer interface (BCI) – aims to evaluate the safety of our implant (N1) and surgical robot (R1) and assess the initial functionality of our BCI for… More.

Continue reading “Neuralink to recruit people with paralysis for first human trials” »